Presumed fluoxetine maculopathy.

Fluoxetina Fluoxetine ISRS OCT SSRIs capas externas de la retina disrupción disruption maculopathy maculopatía outer retinal layer

Journal

Archivos de la Sociedad Espanola de Oftalmologia
ISSN: 2173-5794
Titre abrégé: Arch Soc Esp Oftalmol (Engl Ed)
Pays: Spain
ID NLM: 101715860

Informations de publication

Date de publication:
23 Apr 2024
Historique:
received: 19 01 2024
accepted: 02 03 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 25 4 2024
Statut: aheadofprint

Résumé

To report a unique case of a patient who developed simultaneous bilateral maculopathy presumed from intake of fluoxetine. The optic coherence tomography (OCT) macular showed a subfoveal disruption in the outer retinal layer in both eyes (OU), higher in the left one (OS). Although reported cases of serotonin recapture inhibitors (SSRIs) Maculopathy so far have been caused by sertraline, fluoxetine shares the biological mechanism, and OCT findings and ocular symptoms are the same as published. We should be aware with ocular symptoms in patients that take fluoxetine.

Identifiants

pubmed: 38663717
pii: S2173-5794(24)00072-0
doi: 10.1016/j.oftale.2024.04.010
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Naroa Moreno Benito (NM)

Servicio oftalmología, Hospital de Basurto, Bilbao. Spain.

Paula Belén Blasco Palacio (PBB)

Servicio oftalmología, Hospital de Basurto, Bilbao. Spain. Electronic address: polblascozaragoza@hotmail.com.

Ignacio Rodríguez García (IR)

Servicio oftalmología, Hospital de Basurto, Bilbao. Spain.

Classifications MeSH